PubMed Health⌕ Search

Biomedical subjects

D Schottenfeld

Publications and source records attributed to D Schottenfeld.

134 records · Page 8Linked to original sources

Chronic disease in the workplace and environment: cancer.

The quest for the etiology and prevention of cancer has stimulated a vast frontier of scientific investigations concerning the biochemical and genetic mechanisms that control cell differentiation and proliferation. The contribution of cancer epidemiology to cancer prevention is in identifying risk factors, providing clues for understanding etiologic mechanisms, and in developing the scientific rationale for the effective application of preventive measures. Carcinogenesis involves a complex interplay of environment and heredity. If there is a unifying principle, it is that carcinogenesis is a multistage process. A common oncogenic pathway involves molecular activation of transforming genes. Various links with this pathway may be triggered by environmental and host factors. Transformation of a normal cell to a cancer cell represents a self-perpetuating programming error. Normal cells may indeed harbor the seeds of transformation in the form of cancer genes. These cancer genes may be closely linked with the vital components of the genetic apparatus of a cell. The stage of initiation may involve the unveiling or derepression of cancer genes. However, it would be overly simplistic to assume that the activation of cellular oncogenes was the only aberration necessary and sufficient for malignant transformation. The proliferation of a clone of malignant cells involves the interaction of multiple factors. Promotional events are potentially reversible or modifiable. Herein lies a challenging path of research. Namely, through understanding of the dynamic events that affect tumor growth and host susceptibility, preventive strategies for reversing aberrant cellular proliferation will ultimately be developed and then subjected to rigorous experimental trial.(ABSTRACT TRUNCATED AT 250 WORDS)

Animals↗

The natural history of cervical intraepithelial neoplasia: an argument for intermediate endpoint biomarkers.

Cervical cancer is the second most common malignancy in women worldwide and remains a significant health problem for women, especially minority women in the United States. Despite morbid and costly treatment with whole pelvic radiotherapy, radical surgery, and chemotherapy, the overall survival remains 40%. While the epidemiological risk factors are well known, little is known of the pathobiology of cervical carcinogenesis. Prevention of cervical cancer and its precursors is an important objective. New strategies, both clinical and laboratory based, are desperately needed. Cellular and molecular characteristics of the pathobiology of cervical cancer and its precursors need to be quantified, thereby providing insights into the multistep process of cervical carcinogenesis, identifying those precancerous lesions at high risk for progression to invasion, providing potential targets for intervention, and providing intermediate end point biomarkers for chemopreventive therapies. The premise for this strategy in cervical cancer prevention is that squamous cancers of the female genital tract have a well defined preinvasive stage, and that carcinogenesis is a multistep genetic process which involves increasing dysregulation of proliferation and differentiation as lesions progress from normal to human papillomavirus infected tissue to cervical intraepithelial neoplasia to cancer.

Carcinoma, Squamous Cell↗